PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load | Scientific Reports
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy | PLOS ONE
Anti-PD-1 Blocking Antibody Inhibits Murine Melanoma Growth in... | Download Scientific Diagram
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | NEJM
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy | Journal of the American Chemical Society
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker - Wang - 2020 - Cancer Medicine - Wiley Online Library
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
InVivoMAb anti-mouse CTLA-4 (CD152, Clone: 9D9) | Bio X Cell
PD-1 Specific 'Blocking' Antibodies That Deplete PD-1+ T Cells Present An Inconvenient Variable In Pre-clinical Immunotherapy Experiments | bioRxiv
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
PD-L1 Neutralizing Antibody
PD1 Antibody Selection Tool | Bio X Cell
Anti-PD-1 Neutralizing Antibody
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer | Journal for ImmunoTherapy of Cancer
PD-1 PD-L1 Blockade Bioassay | PD1 PDL1 | PD1 PDL1 Interactions
